Mechanism of Endotoxin's Effect On Allergy Risk
Mechanism of Endotoxin's Effect On Allergy Risk
批准号:
7347534
负责人:
Keoki Williams
金额:
$57.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-15 至 2010-01-31
关键词:
AgeAge-YearsAllergicAntigensAreaAsthmaBindingBirthCD14 AntigenCD14 geneCD4 Positive T LymphocytesCell Differentiation processCellsChildConditionCountryDataDevelopmentDiseaseEndotoxinsEnvironmental ExposureEventExposure toFamilyGenesGenetic PolymorphismGenetic Predisposition to DiseaseHelper-Inducer T-LymphocyteHome environmentHygieneHypersensitivityImmune systemInfectionInfectious AgentInflammatoryInterferonsInterleukin-10Interleukin-4LifeLipopolysaccharidesMeasuresMediatingMutationNumbersPathway interactionsPeripheral Blood Mononuclear CellPhenotypePrevalencePreventionProductionRangeReceptor SignalingResearchResearch DesignRiskRoleSeriesSerologicalSingle Nucleotide PolymorphismSkinT-LymphocyteTestingTimeToll-Like Receptor 2Toll-Like Receptor PathwayToll-like receptorsTranscriptional ActivationUmbilical Cord BloodUnited StatesUp-Regulationanergyatopycohortcytokineenvironmental endotoxingene environment interactionprospectiveprotective effectreceptorresponsetoll-like receptor 4
中文摘要
描述(由申请人提供):许多研究表明,早期暴露于内毒素与较低的哮喘和过敏风险相关。这项研究的总体目标是了解这种效应的机制。这包括1)阐明内毒素是否通过toll样受体(TLRs)的结合和激活介导其作用,以及2)确定内毒素在t细胞分化中的作用。已知toll样受体(TLR)-2、TLR-4和cd14与内毒素结合并介导其对先天免疫系统的刺激。目前尚不清楚这一途径是否也介导了内毒素对过敏的影响。由于2型辅助性t细胞(Th2)似乎负责过敏表达,内毒素可能的下游作用是抑制这种t细胞表型。由于TLR家族识别广泛的感染性有机体,阐明这一机制对长期存在但未经证实的“卫生假说”具有明显的意义,该假说假定早期感染与过敏发展之间存在保护性联系。这里提出的研究将利用2003年9月在底特律地区开始的一个大型的、前瞻性的、多种族的出生队列。为了实现第一个目标,内毒素水平将在出生后的第一年在家中测量,并与随后的血清学和皮肤刺痛测量相关联。将研究已知引起CD14、TLR-2和TLR-4表达或功能改变的单核苷酸多态性(SNPs)。如果TLR通路介导了内毒素对过敏的影响,那么具有这些多态性的儿童对内毒素的反应应该会改变或减弱。第二个目标将确定内毒素暴露是否会导致辅助性t细胞表型(即Thl vs. Th2)的倾斜,或者是否会导致t细胞能量。为了实现这一目标,将前瞻性地测量CD4+淋巴细胞内细胞因子的产生。将在6个月、1岁和2岁时测定脐带血中的白细胞介素(IL)-4、IL-10和干扰素-3。由于CD4+/CD25+调节性t细胞似乎负责能量,随着时间的推移,这组细胞的变化将与内毒素暴露水平有关。希望通过对内毒素作用机制的了解,为预防过敏建立新的靶点。
英文摘要
DESCRIPTION (provided by applicant): A number of studies suggest that early exposure to endotoxin is associated with a lower risk of asthma and allergies. The overall objective of this research is to understand the mechanism of that effect. This includes 1) clarifying whether endotoxin mediates its effect through the binding and activation of Toll-like receptors (TLRs), and 2) determining endotoxin's role in T-cell differentiation. Toll-like receptor (TLR)-2, TLR-4, and CD 14 are known to bind endotoxin and to mediate its stimulation of the innate immune system. What is not known is whether this pathway also mediates endotoxin's effect on allergy. As type-2 helper T-cells (Th2) appear to be responsible for allergic expression, endotoxin's probable downstream effect is suppression of this T-cell phenotype. Since the TLR family recognizes a broad range of infectious organisms, clarifying this mechanism has obvious implications for long-standing, but unproven, "Hygiene Hypothesis," which posits a protective association between early infections and allergic development. The research proposed here will take advantage of a large, prospective, multi-ethnic, birth cohort which began in the Detroit area in September 2003. To achieve the first objective, endotoxin levels will be measured in the home in the first year of life and related to subsequent serologic and skin prick measures of atopy. Single nucleotide polymorphisms (SNPs) known to cause alterations in either the expression or the function of CD14, TLR-2, and TLR-4 will be studied. If the TLR pathway mediates endotoxin's effect on allergy, children with these polymorphisms should display an altered or diminished response to endotoxin. The second objective will determine whether endotoxin exposure results in skewing of the helper T-cell phenotype (i.e., Thl vs. Th2) or whether it results in T-cell anergy. To achieve this objective, intracellular cytokine production in CD4+ lymphocytes will be prospectively measured. Interleukin (IL)-4, IL-10, and interferon-3, will be measured in cord blood, at 6 months, 1 year, and 2 years of age. As CD4+/CD25+ regulatory T-cells appear to be responsible for anergy, changes in this group of cells over time will be related to the level of endotoxin exposure. It is the hoped that understanding the mechanism of endotoxin's effect will establish new targets for the prevention of allergies.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
High-resolution characterization of human leukocyte antigen genes in diverse populations to study the genetics of food allergy
-
批准号:10665162
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2022
-
负责人:Keoki Williams
-
依托单位:
Poly-omic Study of Asthma Exacerbations in Diverse Populations
-
批准号:10094077
-
项目类别:
-
资助金额:$74.48万
-
财政年份:2019
-
负责人:Keoki Williams
-
依托单位:
Poly-omic Study of Asthma Exacerbations in Diverse Populations
-
批准号:10337191
-
项目类别:
-
资助金额:$73.95万
-
财政年份:2019
-
负责人:Keoki Williams
-
依托单位:
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations
-
批准号:9895775
-
项目类别:
-
资助金额:$63.59万
-
财政年份:2017
-
负责人:Keoki Williams
-
依托单位:
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations
-
批准号:9283738
-
项目类别:
-
资助金额:$64.2万
-
财政年份:2017
-
负责人:Keoki Williams
-
依托单位:
Combined Transcriptomics and Genomics to Find Asthma Genes in Admixed Populations
-
批准号:9002073
-
项目类别:
-
资助金额:$72.75万
-
财政年份:2014
-
负责人:Keoki Williams
-
依托单位:
Combined Transcriptomics and Genomics to Find Asthma Genes in Admixed Populations
-
批准号:8795754
-
项目类别:
-
资助金额:$71.83万
-
财政年份:2014
-
负责人:Keoki Williams
-
依托单位:
Combined Transcriptomics and Genomics to Find Asthma Genes in Admixed Populations
-
批准号:8629342
-
项目类别:
-
资助金额:$74.14万
-
财政年份:2014
-
负责人:Keoki Williams
-
依托单位:
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMA
-
批准号:7649069
-
项目类别:
-
资助金额:$72.38万
-
财政年份:2009
-
负责人:Keoki Williams
-
依托单位:
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMA
-
批准号:8035465
-
项目类别:
-
资助金额:$71.3万
-
财政年份:2009
-
负责人:Keoki Williams
-
依托单位:
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMA
-
批准号:7912178
-
项目类别:
-
资助金额:$40.16万
-
财政年份:2009
-
负责人:Keoki Williams
-
依托单位:
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMA
-
批准号:8435330
-
项目类别:
-
资助金额:$66.89万
-
财政年份:2009
-
负责人:Keoki Williams
-
依托单位:
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMA
-
批准号:8228092
-
项目类别:
-
资助金额:$70.85万
-
财政年份:2009
-
负责人:Keoki Williams
-
依托单位:
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMA
-
批准号:7778336
-
项目类别:
-
资助金额:$73.26万
-
财政年份:2009
-
负责人:Keoki Williams
-
依托单位:
USING INFORMATION TECHNOLOGY TO IMPROVE ASTHMA ADHERENCE
-
批准号:6970551
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2005
-
负责人:Keoki Williams
-
依托单位:
USING INFORMATION TECHNOLOGY TO IMPROVE ASTHMA ADHERENCE
-
批准号:7455965
-
项目类别:
-
资助金额:$33.91万
-
财政年份:2005
-
负责人:Keoki Williams
-
依托单位:
USING INFORMATION TECHNOLOGY TO IMPROVE ASTHMA ADHERENCE
-
批准号:7234845
-
项目类别:
-
资助金额:$33.92万
-
财政年份:2005
-
负责人:Keoki Williams
-
依托单位:
USING INFORMATION TECHNOLOGY TO IMPROVE ASTHMA ADHERENCE
-
批准号:7116251
-
项目类别:
-
资助金额:$34.94万
-
财政年份:2005
-
负责人:Keoki Williams
-
依托单位:
Mechanism of Endotoxin's Effect On Allergy Risk
-
批准号:6935332
-
项目类别:
-
资助金额:$71.37万
-
财政年份:2004
-
负责人:Keoki Williams
-
依托单位:
Mechanism of Endotoxin's Effect On Allergy Risk
-
批准号:6830956
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2004
-
负责人:Keoki Williams
-
依托单位:
海外基金